choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Rigel Pharmaceuticals Shares

Rigel Pharmaceuticals Shares Newsletter
  • Earnings Outlook For Rigel Pharmaceuticals 04 Mar 2024 18:38 GMT

    … the announcement. Analysts estimate that Rigel Pharmaceuticals will report an earnings per … .0% 22.0% Stock Performance Shares of Rigel Pharmaceuticals were trading at $1 … track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar on …

  • Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Cross Above 200-Day Moving Average of $1.14 31 Jan 2024 09:12 GMT

    … high as $1.30. Rigel Pharmaceuticals shares last traded at $1. … 00 target price on shares of Rigel Pharmaceuticals in a research … boosted its holdings in shares of Rigel Pharmaceuticals by 7.6% … increased its stake in shares of Rigel Pharmaceuticals by 100.0% …

  • HC Wainwright Reaffirms Buy Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) 04 Jan 2024 19:27 GMT

    … increased its holdings in shares of Rigel Pharmaceuticals by 218.2% … lifted its position in shares of Rigel Pharmaceuticals by 177.3% in … its position in shares of Rigel Pharmaceuticals by 198.6% … its position in shares of Rigel Pharmaceuticals by 14.0% in …

  • HC Wainwright Reaffirms “Buy” Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) 12 Dec 2023 08:03 GMT

    … reiterated their buy rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report … Ohio increased its holdings in shares of Rigel Pharmaceuticals by 8.5% during … ,334 shares during the period. Natixis bought a new stake in Rigel Pharmaceuticals …

  • Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to “Hold” at StockNews.com 05 Nov 2023 11:47 GMT

    StockNews.com cut shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) from … .00 target price on shares of Rigel Pharmaceuticals in a research note on … LLC boosted its position in shares of Rigel Pharmaceuticals by 100.0% during …

  • Rigel Pharmaceuticals (RIGL) to Release Quarterly Earnings on Tuesday 01 Nov 2023 13:51 GMT

    … year. Rigel Pharmaceuticals Trading Down 0.9 % Shares of Rigel Pharmaceuticals stock opened … at $0.80 on Wednesday. Rigel Pharmaceuticals … .00 price target on shares of Rigel Pharmaceuticals in a research report …

  • Rigel Pharmaceuticals (NASDAQ:RIGL) Lifted to Buy at StockNews.com 30 Oct 2023 06:52 GMT

    … 00 price target on shares of Rigel Pharmaceuticals in a research … raised its position in shares of Rigel Pharmaceuticals by 218.2% … boosted its stake in shares of Rigel Pharmaceuticals by 177.3% during … its stake in shares of Rigel Pharmaceuticals by 517.3% …

  • StockNews.com Downgrades Rigel Pharmaceuticals (NASDAQ:RIGL) to Hold 23 Oct 2023 07:39 GMT

    StockNews.com lowered shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) from … .00 price objective on shares of Rigel Pharmaceuticals in a research report on … . Get Our Latest Analysis on Rigel Pharmaceuticals Rigel Pharmaceuticals Trading Down 4.8 % …

  • Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Rating Upgraded by StockNews.com 15 Oct 2023 09:27 GMT

    … .00 price objective on shares of Rigel Pharmaceuticals in a research note … on Rigel Pharmaceuticals Rigel Pharmaceuticals Stock Performance Want More Great Investing Ideas? Shares of … raised its position in shares of Rigel Pharmaceuticals by 218.2% during …

  • Rigel Pharmaceuticals (RIGL) to Release Quarterly Earnings on Tuesday 26 Jul 2023 21:03 GMT

    … the next fiscal year. Rigel Pharmaceuticals Price Performance Shares of NASDAQ:RIGL traded … acquired a new position in shares of Rigel Pharmaceuticals in the third quarter … acquired a new stake in shares of Rigel Pharmaceuticals during the first quarter …

Satisfied with the content?

Continue to create your account.